INSMED INC Payments to Acquire Short-term Investments
INSMED INC (INSM) reported Payments to Acquire Short-term Investments of $19.66 million for the 12-month period ending 2012-12-31, per its 10-K filed 2015-02-27.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireShortTermInvestments · last filed 2015-02-27
- INSMED INC payments to acquire short-term investments for the quarter ending 2012-12-31 was $19.66M.
- INSMED INC payments to acquire short-term investments for the quarter ending 2012-09-30 was $0.00, a 100.00% decline year-over-year.
- INSMED INC payments to acquire short-term investments for the quarter ending 2012-06-30 was $0.00, a 100.00% decline year-over-year.
- INSMED INC payments to acquire short-term investments for the quarter ending 2012-03-31 was $0.00, a 100.00% decline year-over-year.
- INSMED INC payments to acquire short-term investments for fiscal 2012 was $19.66M, a 1593.11% increase from fiscal 2011.
- INSMED INC payments to acquire short-term investments for fiscal 2011 was $1.16M, a 98.87% decline from fiscal 2010.
- INSMED INC payments to acquire short-term investments for fiscal 2010 was $102.46M, a 5.78% decline from fiscal 2009.
- INSMED INC payments to acquire short-term investments for fiscal 2009 was $108.74M.
| Period end | Payments to Acquire Short-term Investments 3 month | Payments to Acquire Short-term Investments 6 month | Payments to Acquire Short-term Investments 6 month as first filed | Payments to Acquire Short-term Investments 9 month | Payments to Acquire Short-term Investments 9 month as first filed | Payments to Acquire Short-term Investments 12 month |
|---|---|---|---|---|---|---|
| 2012-12-31 | $19.66M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | $19.66M derived: sum of 2 quarters · filed 2015-02-27 | $19.66M derived: sum of 3 quarters · filed 2015-02-27 | $19.66M 10-K · filed 2015-02-27 | ||
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-07 | $0.00 derived: sum of 2 quarters · filed 2012-11-07 | $0.00 10-Q · filed 2012-11-07 | -$424.00K derived: sum of 4 quarters · filed 2014-03-06 | ||
| 2012-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-07 | $0.00 10-Q · filed 2012-08-07 | -$424.00K derived: sum of 3 quarters · filed 2014-03-06 | -$302.00K derived: sum of 4 quarters · filed 2014-03-06 | ||
| 2012-03-31 | $0.00 10-Q · filed 2012-05-08 | -$424.00K derived: sum of 2 quarters · filed 2014-03-06 | -$302.00K derived: sum of 3 quarters · filed 2014-03-06 | $1.07M derived: sum of 4 quarters · filed 2014-03-06 | ||
| 2011-12-31 | -$424.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-06 | -$302.00K derived: sum of 2 quarters · filed 2014-03-06 | $1.07M derived: sum of 3 quarters · filed 2014-03-06 | $1.16M 10-K · filed 2014-03-06 | ||
| 2011-09-30 | $122.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-07 | $1.50M derived: sum of 2 quarters · filed 2012-11-07 | $1.58M 10-Q · filed 2012-11-07 | -$1.58M 10-Q · filed 2011-11-09 | $198.80M derived: sum of 4 quarters · filed 2013-03-18 | |
| 2011-06-30 | $1.38M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-07 | $1.46M 10-Q · filed 2012-08-07 | -$1.46M 10-Q/A · filed 2011-08-08 | $198.68M derived: sum of 3 quarters · filed 2013-03-18 | $176.59M derived: sum of 4 quarters · filed 2013-03-18 | |
| 2011-03-31 | $87.00K 10-Q · filed 2012-05-08 | $197.31M derived: sum of 2 quarters · filed 2013-03-18 | $175.22M derived: sum of 3 quarters · filed 2013-03-18 | |||
| 2010-12-31 | $197.22M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | $175.13M derived: sum of 2 quarters · filed 2013-03-18 | $102.46M 10-K · filed 2013-03-18 | |||
| 2010-09-30 | -$22.09M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2011-11-09 | -$94.76M 10-Q · filed 2011-11-09 | ||||
| 2010-06-30 | -$72.67M 10-Q/A · filed 2011-08-08 | |||||
| 2009-12-31 | $108.74M 10-K · filed 2012-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |